BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 35087408)

  • 1. Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus.
    Yang Y; Luan Y; Feng Q; Chen X; Qin B; Ren KD; Luan Y
    Front Pharmacol; 2021; 12():807413. PubMed ID: 35087408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.
    Jazieh C; Arabi TZ; Asim Z; Sabbah BN; Alsaud AW; Alkattan K; Yaqinuddin A
    Front Endocrinol (Lausanne); 2024; 15():1295967. PubMed ID: 38323108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus.
    Mannar V; Boro H; Patel D; Agstam S; Dalvi M; Bundela V
    touchREV Endocrinol; 2023 May; 19(1):46-53. PubMed ID: 37313245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus.
    Liu J; Lang G; Shi J
    Diabetes Metab Syndr Obes; 2021; 14():431-442. PubMed ID: 33564250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and type II diabetes mellitus: underlying mechanisms of prenatal predisposition.
    Sterns JD; Smith CB; Steele JR; Stevenson KL; Gallicano GI
    Front Cell Dev Biol; 2014; 2():15. PubMed ID: 25364722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes.
    Ding Q; Gao Z; Chen K; Zhang Q; Hu S; Zhao L
    Front Immunol; 2022; 13():883410. PubMed ID: 35603204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.
    Muka T; Nano J; Voortman T; Braun KVE; Ligthart S; Stranges S; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):553-566. PubMed ID: 27146363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes.
    Ling C
    J Intern Med; 2020 Aug; 288(2):158-167. PubMed ID: 32363639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Epigenetics in Type 1 Diabetes.
    Xie Z; Chang C; Huang G; Zhou Z
    Adv Exp Med Biol; 2020; 1253():223-257. PubMed ID: 32445098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation landscapes in the pathogenesis of type 2 diabetes mellitus.
    Zhou Z; Sun B; Li X; Zhu C
    Nutr Metab (Lond); 2018; 15():47. PubMed ID: 29988495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases.
    Hickok JR; Vasudevan D; Antholine WE; Thomas DD
    J Biol Chem; 2013 May; 288(22):16004-15. PubMed ID: 23546878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of demethylases in cardiac development and disease.
    Davis K; Azarcon P; Hickenlooper S; Bia R; Horiuchi E; Szulik MW; Franklin S
    J Mol Cell Cardiol; 2021 Sep; 158():89-100. PubMed ID: 34081951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylases.
    Lillico R; Sobral MG; Stesco N; Lakowski TM
    J Proteomics; 2016 Feb; 133():125-133. PubMed ID: 26721445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases.
    Yang Y; Luan Y; Yuan RX; Luan Y
    Front Cardiovasc Med; 2021; 8():710053. PubMed ID: 34568453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in genetic and epigenetic research on type 2 diabetes.
    Kwak SH; Park KS
    Exp Mol Med; 2016 Mar; 48(3):e220. PubMed ID: 26964836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus.
    Zampieri M; Bacalini MG; Barchetta I; Scalea S; Cimini FA; Bertoccini L; Tagliatesta S; De Matteis G; Zardo G; Cavallo MG; Reale A
    Clin Epigenetics; 2021 May; 13(1):114. PubMed ID: 34001206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus.
    Ramírez-Alarcón K; Victoriano M; Mardones L; Villagran M; Al-Harrasi A; Al-Rawahi A; Cruz-Martins N; Sharifi-Rad J; Martorell M
    Front Endocrinol (Lausanne); 2021; 12():656978. PubMed ID: 34140928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function and Regulation of Histone H3 Lysine-4 Methylation During Oocyte Meiosis and Maternal-to-Zygotic Transition.
    Sha QQ; Zhang J; Fan HY
    Front Cell Dev Biol; 2020; 8():597498. PubMed ID: 33163498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.
    Ahmed SAH; Ansari SA; Mensah-Brown EPK; Emerald BS
    Clin Epigenetics; 2020 Jul; 12(1):104. PubMed ID: 32653024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.